List of bibliographic references
Number of relevant bibliographic references: 5.
List of associated KwdEn.i
Nombre de
documents | Descripteur |
|---|
| 3 | Fusion Proteins, bcr-abl (genetics) |
| 3 | Humans |
| 2 | DNA Mutational Analysis (methods) |
| 2 | Drug Resistance, Neoplasm (genetics) |
| 2 | Leukemia, Myelogenous, Chronic, BCR-ABL Positive (drug therapy) |
| 2 | Leukemia, Myelogenous, Chronic, BCR-ABL Positive (genetics) |
| 2 | Protein Kinase Inhibitors (therapeutic use) |
| 1 | Adolescent |
| 1 | Adult |
| 1 | Aged |
| 1 | Aged, 80 and over |
| 1 | Amino Acid Substitution |
| 1 | Antineoplastic Combined Chemotherapy Protocols (administration & dosage) |
| 1 | Antineoplastic Combined Chemotherapy Protocols (adverse effects) |
| 1 | Antineoplastic agent |
| 1 | Chemotherapy, Adjuvant |
| 1 | Chronic myelocytic leukemia |
| 1 | Cytogenetics |
| 1 | DNA Mutational Analysis (trends) |
| 1 | Disease-Free Survival |
| 1 | Drug-Related Side Effects and Adverse Reactions (classification) |
| 1 | Drug-Related Side Effects and Adverse Reactions (pathology) |
| 1 | Enzyme inhibitor |
| 1 | Female |
| 1 | Forecasting |
| 1 | Hematology |
| 1 | High-Throughput Nucleotide Sequencing |
| 1 | Human |
| 1 | Imatinib |
| 1 | Imatinib Mesylate (administration & dosage) |
| 1 | Imatinib Mesylate (adverse effects) |
| 1 | Imidazoles (administration & dosage) |
| 1 | Imidazoles (adverse effects) |
| 1 | Imidazoles (therapeutic use) |
| 1 | Kaplan-Meier Estimate |
| 1 | Leukemia, Myelogenous, Chronic, BCR-ABL Positive (pathology) |
| 1 | Leukemia, Myeloid, Chronic-Phase (drug therapy) |
| 1 | Leukemia, Myeloid, Chronic-Phase (genetics) |
| 1 | Male |
| 1 | Middle Aged |
| 1 | Mutation |
| 1 | Mutation (physiology) |
| 1 | Neoadjuvant Therapy |
| 1 | Philadelphia Chromosome (drug effects) |
| 1 | Practice Guidelines as Topic |
| 1 | Prognosis |
| 1 | Protein Kinase Inhibitors (pharmacology) |
| 1 | Protein-tyrosine kinase |
| 1 | Pyridazines (administration & dosage) |
| 1 | Pyridazines (adverse effects) |
| 1 | Pyridazines (therapeutic use) |
| 1 | Treatment Outcome |
| 1 | Treatment resistance |
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/Allemagne/Analysis
HfdIndexSelect -h $EXPLOR_AREA/Data/Allemagne/Analysis/Author.i -k "Moshe Talpaz"
HfdIndexSelect -h $EXPLOR_AREA/Data/Allemagne/Analysis/Author.i \
-Sk "Moshe Talpaz" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Allemagne/Analysis/biblio.hfd
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Asie
|area= AustralieFrV1
|flux= Allemagne
|étape= Analysis
|type= indexItem
|index= Author.i
|clé= Moshe Talpaz
}}
| This area was generated with Dilib version V0.6.33.
Data generation: Tue Dec 5 10:43:12 2017. Site generation: Tue Mar 5 14:07:20 2024 |  |
